MARKET

TCMD

TCMD

Tactile Sys Tech
NASDAQ

Real-time Quotes | Nasdaq Last Sale

42.10
-0.07
-0.17%
Closed 17:47 09/16 EDT
OPEN
42.26
PREV CLOSE
42.17
HIGH
43.80
LOW
41.15
VOLUME
75.94K
TURNOVER
--
52 WEEK HIGH
64.53
52 WEEK LOW
30.31
MARKET CAP
832.83M
P/E (TTM)
60.63
1D
5D
1M
3M
1Y
5Y
BRIEF-Tactile Medical Announces Acquisition Of Afflovest
reuters.com · 09/08 20:18
Tactile Medical to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
Tactile Systems Technology, Inc. ("Tactile Medical") (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases at home, today announced that management will participate in the Morgan Stanley 19...
GlobeNewswire · 08/31 20:05
Looking into Tactile Systems Tech's Return on Capital Employed
After pulling data from Benzinga Pro it seems like during Q2, Tactile Systems Tech (NASDAQ:TCMD) posted sales of $51.06 million. Earnings were up 98.14%, but Tactile Systems Tech still reported an overall loss of $76.00 thousand.
Benzinga · 08/19 15:20
Return on Capital Employed Overview: Tactile Systems Tech
After pulling data from Benzinga Pro it seems like during Q2, Tactile Systems Tech (NASDAQ:TCMD) posted sales of $51.06 million. Earnings were up 98.14%, but Tactile Systems Tech still reported an overall loss of $76.00 thousand.
Benzinga · 08/12 15:22
Tactile Medical to Present at the Guggenheim 2021 MedTech Disruptors Summit
MINNEAPOLIS, Aug. 04, 2021 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases at home, today announced that manag...
GlobeNewswire · 08/04 20:05
Did You Miss Tactile Systems Technology's (NASDAQ:TCMD) Impressive 250% Share Price Gain?
The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But on the bright side, if...
Simply Wall St. · 08/03 13:21
Tactile Systems Technology (TCMD) Reports Break-Even Earnings for Q2
Zacks.com · 08/02 22:25
Recap: Tactile Systems Tech Q2 Earnings
Shares of Tactile Systems Tech (NASDAQ:TCMD) were flat in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share increased 113.73% year over year to $0.07, which beat the estimate of $0.01.
Benzinga · 08/02 21:19
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of TCMD. Analyze the recent business situations of Tactile Sys Tech through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 5 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average TCMD stock price target is 70.00 with a high estimate of 75.00 and a low estimate of 62.00.
EPS
Institutional Holdings
Institutions: 241
Institutional Holdings: 23.10M
% Owned: 116.77%
Shares Outstanding: 19.78M
TypeInstitutionsShares
Increased
59
2.03M
New
8
192.64K
Decreased
42
1.06M
Sold Out
11
174.48K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+0.13%
Healthcare Equipment & Supplies
-0.15%
Key Executives
Non-Executive Chairman/Independent Director
Peter Soderberg
President/Chief Executive Officer/Director
Daniel Reuvers
Chief Financial Officer
Brent Moen
Senior Vice President/Director of Sales
Eric Pauls
Senior Vice President/Director of Marketing
Kristie Burns
Senior Vice President
Darren Wennen
Independent Director
William Burke
Independent Director
Sheri Dodd
Independent Director
Raymond Huggenberger
Independent Director
Deepti Jain
Independent Director
Richard Nigon
Independent Director
Kevin Roche
No Data
About TCMD
Tactile Systems Technology, Inc. is a medical technology company that develops and provides medical devices for the treatment of chronic diseases at home. The Company is a manufacturer and distributor of the Flexitouch and Entre Systems, medical devices that help control symptoms of lymphedema, a chronic and progressive medical condition that is often an unintended consequence of cancer treatment, and the ACTitouch System, a medical device used to treat venous leg ulcers and chronic venous insufficiency. Its products deliver long-term treatment of chronic diseases. The Company provides its products for use in the home and sells them through vascular, wound and lymphedema clinics throughout the United States. The Company offers a platform to deliver at-home healthcare solutions throughout the United States. Its initial area of therapeutic focus is vascular disease, with a focus on advancing the care in treating lymphedema and chronic venous insufficiency.

Webull offers kinds of Tactile Systems Technology Inc stock information, including NASDAQ:TCMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TCMD stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading TCMD stock methods without spending real money on the virtual paper trading platform.